Spruce Biosciences (SPRB) Balance Sheet: Assets & Liabilities

Spruce Biosciences (SPRB) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Spruce Biosciences reported total assets of $53.02M and total liabilities of $10.51M. Shareholders' equity was $42.52M, up 47.5% from $28.82M a year earlier. Total debt stood at $736.00K against $48.91M in cash and short-term investments, a net cash position of $48.17M. That puts debt-to-equity at 0.02, compared with 0.10 a year earlier.

Spruce Biosciences Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Spruce Biosciences, Inc. (SPRB) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	48.91	38.75	96.34	24.49	42.75	157.15	3.92	4.11
Short-Term Investments	0.00	0.00	0.00	54.59	46.22	0.00	0.00	0.00
Cash & Short-Term Investments	48.91	38.75	96.34	79.08	88.97	157.15	3.92	4.11
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	3.21	5.45	5.84	1.21	0.40	3.25	0.73	0.66
Total Current Assets	52.11	44.21	102.18	83.61	91.90	160.40	4.65	4.77
Non-Current Assets
Property, Plant & Equipment (Net)	0.67	0.93	1.18	1.40	1.48	1.87	0.00	0.00
Long-Term Investments	0.00	0.00	0.00	0.00	32.46	0.00	0.00	0.00
Other Non-Current Assets	0.24	0.07	0.58	0.64	0.65	0.62	0.04	0.00
Total Non-Current Assets	0.91	1.00	1.76	2.04	34.59	2.49	0.04	0.00
Total Assets	53.02	45.21	103.95	85.65	126.49	162.88	4.69	4.78
Current Liabilities
Accounts Payable	0.94	1.30	3.33	1.43	2.82	3.63	1.88	2.30
Short-Term Debt	0.32	1.91	1.62	1.62	0.36	2.80	1.25	0.00
Current Portion of Long-Term Debt	-	1.62	1.62	1.62	-	2.55	-	-
Accrued Liabilities	7.05	12.33	14.60	7.97	4.25	3.33	-	-
Deferred Revenue	0.00	0.00	4.91	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	8.83	12.05	14.35	9.26	5.69	3.33	1.17	0.41
Total Current Liabilities	10.09	15.25	24.47	12.45	8.87	9.76	4.30	2.71
Non-Current Liabilities
Long-Term Debt	0.42	0.86	1.72	3.29	4.88	3.58	3.19	0.00
Other Non-Current Liabilities	0.00	0.28	0.24	0.16	0.07	0.12	27.83	19.87
Total Non-Current Liabilities	0.42	1.14	2.97	4.72	6.24	3.69	31.03	19.87
Total Liabilities	10.51	16.39	27.44	17.16	15.12	13.46	35.33	22.58
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-289.23	-250.27	-197.23	-149.31	-103.13	-60.84	-31.30	-18.21
Accumulated Other Comprehensive Income	0.00	0.00	0.00	-0.56	-0.18	-	-27.81	0.00
Additional Paid-in Capital	331.75	279.09	273.74	218.35	214.69	210.27	0.66	-19.87
Shares Outstanding	1.37	0.56	0.55	0.31	0.31	-	-	-
Total Stockholders' Equity	42.52	28.82	76.51	68.49	111.37	149.43	-30.64	-17.80
Total Liabilities & Equity	53.02	45.21	103.95	85.65	126.49	162.88	4.69	4.78

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Spruce Biosciences Balance Sheet

How much debt does Spruce Biosciences have?

Spruce Biosciences had total debt of $736.00K as of Dec 31, 2025, against $48.91M in cash and short-term investments. Its debt-to-equity ratio was 0.02. Total debt was $2.77M a year earlier.

What are Spruce Biosciences's total assets?

Spruce Biosciences reported total assets of $53.02M as of Dec 31, 2025, up 17.3% from $45.21M a year earlier. Total liabilities were $10.51M.

What is Spruce Biosciences's shareholders' equity?

Spruce Biosciences's shareholders' equity was $42.52M as of Dec 31, 2025, or about $30.99 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition